In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intersect ENT Inc.

www.intersectent.com

Latest From Intersect ENT Inc.

Global Device Approvals Snapshot, 23-29 July 2019; Intersect ENT’s Straight Delivery System

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. The week of July 23 to 29 was another slow one for FDA approvals, with no new PMAs, panel-track PMA supplements, de novos, or non-US approvals.

Approvals Innovation

Device Debut: STS' Stent For Chronic Sinusitis Gets US Go-Ahead

The Israeli portfolio company of The Trendlines Group announced that US FDA 510(k)-cleared its composite removable sinus stent system based on results of a 30-patient trial.

Approvals Innovation

Device Debut: Sinuva Marks Next Step In Intersect ENT's Evolution Into A Combo Products Company

US FDA approved a New Drug Application for Intersect ENT's Sinuva mometasone furoate-eluting sinus implant in December. The implant elutes the cortical steroid to treat recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery and is supported by data from 400 patients, including the results from the RESOLVE II trial that showed Sinuva dramatically reduced the proportion of patients who needed another endoscopic sinus surgery.

Ear, Nose & Throat Innovation

2016 Original PMAs And Panel-Track Supplements

A sortable and searchable table of FDA original PMAs and panel-track supplements approved in calendar year 2016, updated monthly. Latest update: approvals through March 31.

Medical Device Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Otolaryngology
  • Alias(es)
  • Sinexus Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Intersect ENT Inc.
  • Senior Management
  • Thomas A West, CEO
    Jeryl Hilleman, CFO
    Susan Stimson, VP, Mktg.
    Robert Binney, VP, Sales
    Rich Kaufman, SVP, COO
    James Stambaugh, VP, Clinical Affairs
    Chas McKhann, Chief Commercial Officer
  • Contact Info
  • Intersect ENT Inc.
    Phone: (650) 641-2100
    1555 Adams Dr.
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register